Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol
Open Access

Embryo Transfer: Implications of Clinical and Embryological Factors

Arfreen Musa^{* *}Correspondence: Arfreen Musa, Department of Obstetrics and Gynaecology, University of Dundee, Dundee, United Kingdom, Email:

Author info »

Description

Supported reproduction ways involves fertilization of the egg and sperm in the laboratory. Also the embryo was transferred into the woman's uterine depression generally by using a catheter which was fitted through the uterine cervix and expecting for them to implant and give rise to a gestation. Several types of catheters are used for this process, still, there's good substantiation that using a soft or hard transfer catheter can increase the chances of clinical gestation. This procedure is the final step in In-Vitro Fertilization (IVF) which is simple and effortless process that doesn't bear anesthesia and will be in three to six days after the oocyte reclamation. This Embryo transfer is done to the cases having fallopian tube damage or blockage, ovulation diseases, uterine fibroids etc. [1].

Embryo Transfer (ET) either fresh or frozen is introductory to the success of fertility treatment. The gestation rates appear to be increased at the time of Embryo Transfer by several generally esposed ways, videlicet ultrasound versus clinical touch, soft vs. hard catheters, and addition of hyaluronic acid as an ‘adherence’ agent to the transfer medium.

Embryo transfer is routinely performed through the transcervical route and can be done either conventionally or by Intra Cytoplasmic Sperm Injection (IVF-ICSI). It's essential that the endometrium is set, that it's open to increase the probability of embryo implantation.

Embryologist will work with you to decide on the number of embryos to transfer. A number of factors will be looked at in making this decision like: Quality and number of embryos recaptured, age of the women, former gravidity, whether you have had a former transfer [2].

When it comes to performing an embryo transfer, there live two possible options:

• Natural cycle is progressed without using artificial drug or just with progesterone supplements. IVF/ICSI cycles are infrequently done without progesterone.

• Stimulated cycle is progressed using hormonal specifics. Estrogen and progesterone are used to prepare the endometrial filling.

The success of your embryo transfer will depend on the following factors:

• Quality of the embryo

• Uterine health

• Number of eggs recaptured

• Quality and volume of sperm cells

• Age of the womanish mate

Embryo implantation failure can occur due to varied reasons including:

• Inheritable or chromosomal abnormalities

• Uterine fibroids

• Scarring or adhesions

• Infections or inflammation in the uterus

• Unseasonable increase in progesterone situations

• Non-receptive endometrial filling

• Advanced age of the womanish mate

• Corpulence

In vitro Fertilization (IVF) has traditionally been performed by the transfer of fresh embryos. Among women who are witnessing In vitro Fertilization (IVF), the transfer of frozen embryos has been shown to affect in an advanced rate of live birth than the transfer of fresh embryos in those with gravidity associated with the polycystic ovary pattern [2].

Different types of embryo transfers

Fresh embryo transfer: A fresh embryo transfer generally occurs 5 days after a case’s eggs are recaptured. The eggs are fertilized with sperm in the laboratory, and the performing embryo is grown and covered nearly. The main benefit of a fresh embryo transfer is that there's a shorter time to generality, since there's only a 5 day staying period between egg reclamation and embryo transfer into the uterus.

There are some contraindications for fresh transfers. However, a fresh transfer shouldn't be done, as this would negatively affect embryo implantation, if a case’s progesterone position is elevated and also, if a case is at threat for hyper stimulation from the specifics used to induce egg development, a fresh transfer could be dangerous for the case [3].

Frozen embryo transfer: A Frozen Embryo Transfer generally occurs 6-8 weeks after the embryo is firmed. When the case is ready for transfer, she's given specifics to mimic a natural menstrual cycle, and the Frozen Embryo Transfer (FET) date is coordinated with the cycle to optimize implantation.

FET is still needed, if a case wishes to have her embryos tested for inheritable abnormalities. Preimplantation Inheritable Testing (PGT) is performed shortly after egg reclamation. The embryo is biopsied (a small sample is taken from the embryo), and that sample, which contains the DNA of the embryo, is estimated for chromosomal and inheritable abnormalities. Once PGT is completed, the embryologist should choose only chromosomally normal embryos for transfer. Only by transferring normal embryos, pregnancy success is greatly improved [4].

Since the Frozen Embryos can be stored they can be used for the next subsequent pregnancies. Also, if a case wishes to save fertility because of age, cancer treatment or other reasons, embryos can be created for after use, and when ready, and FET would be performed.

Blastocyst embryo transfer: If numerous healthy embryos develop after the fertilization, it's common to stay to see if the embryos develop into blastocysts. According to a study in the Indian Journal of Clinical Practice, blastocyst embryo transfer has advanced success rate than the standard embryo transfer on day 3. Another recent study suggests that it may pose pitfalls latterly in gestation and shouldn't always be recommended [4].

Assisted Hatching (AH): A study in the Reproductive Biomedicine Online trusted source set up that the process of supported hatching-weakening the external subcaste of the embryo before it's transferred to the uterus-doesn't ameliorate gestation and implantation rates in women who are having fresh embryos transferred. The experimenters noted, still, that women having firmed embryos implanted do benefit from having their embryos treated in this way.

References

1. Barroso G, Menocal G, Felix H, Rojas-Ruiz JC, Arslan M, Oehninger S. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: A prospective, randomized, blinded clinical trial. Fertil Steril. 2006;86(5):1428-1431.

   [Crossref][Google Scholar][Pubmed]

2. Chen Z, Zhang M, Qiao Y, Yang J. Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pak J Med Sci. 2016;32(6):1434-1438.

   [Crossref][Google Scholar][Pubmed]

3. Groutz A, Lessing JB, Wolf Y, Azem F, Yovel I, Amit A. Comparison of transmyometrial and transcervical embryo transfer in patients with previously failed in vitro fertilization-embryo transfer cycles and/or cervical stenosis. Fertil Steril. 1997;67(6):10736.

   [Crossref][Google Scholar][Pubmed]

4. Gorrill MJ, Kaplan PF, Patton PE, Burry KA. Initial experience with extended culture and blastocyst transfer of cryopreserved embryos. Am J Obstet Gynecol. 1999;180(6):1472-1474.

   [Crossref][Google Scholar][Pubmed]